Following antigen recognition, CD3 (T‐cell receptor) initiates a signaling cascade that activates both CD4+ and CD8+ T cells,32 which are referred to as tumor infiltrating lymphocytes (TILs) and are involved in eliminating tumor cells.33, 34. This evidence concerns the gene CD4 and neoplasm.